康齐祖马布改善了血友病A患者在流动下凝块的形成
Megan P Jewell1, Zaina Ashour1, Christine H Baird2
1Department of Bioengineering, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, USA.
Journal of thrombosis and haemostasis : JTH
|May 30, 2024
概括
作为TFPI抑制剂的康齐祖马布有效促进血小板激活和A型血友病中的纤维素凝块形成,与rFVIIa相似. 这项研究表明,通过在流动条件下增强凝血来治疗血友病A的潜力.
科学领域:
- 血液学 血液学 血液学
- 血液静止和血栓形成
- 药理学 药理学是指药理学的学科.
背景情况:
- 组织因子通路抑制剂 (TFPI) 的抑制是血友病治疗的有前途的治疗策略.
- 康齐祖马布是一种针对TFPI的单克隆抗体,旨在通过阻断TFPI对Xa因子 (FXa) 的抑制来恢复凝血.
研究的目的:
- 为了研究康齐祖马布在血液流动条件下对血友病A型血栓形成的体外效应.
- 为了比较康齐苏马布与重组激活因子VII (rFVIIa) 恢复血静的疗效.
主要方法:
- 模拟血友病A使用正常血液与抗FVIII抗体,和先天性血友病A血液.
- 全血透到组织因子 (TF) 和与原相关的表面,切割速率为100s-1.1.
- 测量血小板和纤维激素积累,以及对rFVIIa和不同度的康齐祖马布反应的静态血栓生成.
主要成果:
- 康齐祖马布 (1000和4000 ng/mL) 和rFVIIa在模拟的血友病A中显著挽救了血小板积累 (93%-101%).
- 这两种药物都使纤维素素的纳入 (53%-63%) 部分恢复到正常水平.
- 与rFVIIa相比,康齐苏马布在静态条件下显示出更大的血中血栓生成增强.
结论:
- 康齐祖马布对TFPI的抑制有效地促进了血小板激活,聚合和血友病A中的纤维素凝块形成.
- 在流量条件下,康齐祖马布的前凝效应与rFVIIa.a.相当.
- 康齐祖马布通过增强凝血,显示出作为血友病A治疗剂的潜力.
相关概念视频
Clot Retraction and Fibrinolysis
5.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K
Formation of the Platelet Plug
5.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.8K
Coagulation
6.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.2K
Introduction to Hemostasis
7.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.3K


